Leukemia inhibitory factor-dependent transcriptional activation in embryonic stem cells

Journal of Cell Biology

Volumn 138, Issue 6, 1997, Pages 1207-1217

  Boeuf, Hélène ^a   Hauss, Charlotte ^a   De Graeve, Fabienne ^a   Baran, Nathalie ^a   Kedinger, Claude ^a  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKEMIA INHIBITORY FACTOR;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA INTERACTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; STEM CELL; TRANSCRIPTION REGULATION;

ACUTE-PHASE PROTEINS; ANIMALS; ANTIBODY SPECIFICITY; BINDING SITES; BLASTOCYST; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GROWTH INHIBITORS; INTERLEUKIN-6; LEUKEMIA INHIBITORY FACTOR; LYMPHOKINES; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MUTAGENESIS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-FOS; RECOMBINANT FUSION PROTEINS; STAT3 TRANSCRIPTION FACTOR; STEM CELLS; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TYROSINE;

ANIMALIA;

EID: 0030875352     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.138.6.1207     Document Type: Article

References (65)

1. Akira, S., Y. Nishio, M. Inoue, X.J. Wang, S. Wei, T. Matsusaka, K. Yoshida, T. Sudo, M. Naruto, and T. Kishimoto. 1994. Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p91-related transcription factor involved in the gp130-mediated signaling pathway. Cell. 77:63-71.
2. Akiyama, T, J. Ishida, S. Nakagawa, H. Ogawara, S. Watanabe, N. Itoh, M. Shibuya, and Y. Fukami. 1987. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262:5592-5595.
3. Boschart, M., M. Kluppel, A. Schmidt, G. Schutz, and B. Luckow. 1992. Reporter constructs with low background activity utilizing the CAT gene. Gene (Amst.). 110:129-130.
4. Boulter, C.A., A. Agguzi, R.L. Williams, E.F. Wagner, M.J. Evans, and R. Beddington. 1993. Expression of v-src induces aberrant development and twinning in chimaeric mice. Development (Camb.). 111:357-366.
5. Boulton, T.G., Z. Zhong, Z. Wen, J.E. Darnell, Jr., and N. Stahl. 1995. STAT3 activation by cytokines utilizing gp130 and related transducers involves a secondary modification requiring an H7-sensitive kinase. Proc. Natl. Acad. Sci. USA. 92:6915-6919.
6. Bradley, A. 1990. Embryonic stem cells: proliferation and differentiation. Cnrr. Opin. Cell Biol. 2:1013-1017.
7. Cao, X., A. Tay, R.G. Graeme, and Y. H. Tan. 1996. Activation and association of STAT3 with Src in V-src-transformed cell lines. Mol. Cell. Biol. 16:1595-1603.
8. Chen, C., and H. Okayama. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:2745-2752.
9. Conover, J.C, N. Y. Ip, W.T. Poueymirou, B. Bates, M.P. Goldfarb, T.M. De Chiara, and G.D. Yancopoulos. 1993. Ciliary neurotrophic factor maintains the pluripotentiality of embryonic stem cells. Development (Camb.). 11:559-565.
10. Cressman, D.E., L.E. Greenbaum, R.A. De Angelis, G. Ciliberto, E.E. Furth, V. Poli, and R. Taub. 1996. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science (Wash. DC). 274: 1379-1383.
11. Darnell, J.E., Jr., I.M. Kerr, and G.R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science (Wash. DC). 264:1415-1421.
12. Darnell, J.E., Jr. 1996. Reflections on STAT3, STATS, and STAT6 as fat STATs. Proc. Natl. Acad. Sci. USA. 93:6221-6224.
13. David, M., E. Petricoin, C. Benjamin, R. Pine, M.J. Weber, and A.C. Larner. 1995. Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins. Science (Wash. DC). 269:1721-1723.
14. Ernst, M., D.P. Gearing, and A.R. Dunn. 1994. Functional and biochemical association of Hck with the LIF/IL-6 receptor signal transducing subunit gp130 in embryonic stem cells. EMBO J. 13:1574-1584.
15. Ernst, M., A. Oates, and A.R. Dunn. 1996. Gp130-mediated signal transduction in embryonic stem cells involves activation of Jak and Ras/mitogen-activated protein kinase pathways. J. Biol. Chem. 271:30136-30143.
16. Escary, J.L., J. Perreau, D. Dumenil, S. Ezine, and P. Brulet. 1993. Leukaemia inhibitory factor is necessary for maintenance of haematopoietic stem cells and thymocyte stimulation. Nature (Lond.). 363:361-364.
17. Fu, X.Y., and J.J. Zhang. 1993. Transcription factor p91 interacts with the epidermal growth factor receptor and mediates activation of the c-fos promoter. Cell. 74:1135-1145.
18. Fukada, T., M. Hibi, Y. Yamanaka, M. Takahashi-Tezuka, Y. Fujitani, T. Yamaguchi, K. Nakajima, and T. Hirano. 1996. Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis. Immunity. 5:449-460.
19. Gorman, C.M., L.F. Moffal, and B.H. Howard. 1982. Recombinant genomes which express chloramphenicol acetyl transferase in mammalian cells. Mol. Cell. Biol. 2:1044-1051.
20. Gouilleux, F., C. Pallard, I. Dusanter-Four, H. Wakao, L.A. Haldosen, G. Norstedt, D. Levy, and B. Groner. 1995. Prolactin, growth hormone, erythropoietin and granulocyte-macrophage colony stimulating factor induce MGF-STAT5 DNA binding activity. EMBO J. 14:2005-2013.
21. Hilton, D.J. 1992. LIF: a lot of interesting functions. Trends Biochem. Sci. 17:72-76.
22. Hirano, T., T. Matsuda, and K. Nakajima. 1994. Signal transduction through gp130 that is shared among the receptors for the interleukin-6 related cytokine subfamily. Stem Cells. 12:262-277.
23. Hocke, G.M., M.Z. Cui, and G.H. Fey. 1995. The LIF response element of the α2 macroglobulin gene confers LIF-induced transcriptional activation in embryonal stem cells. Cytokine. 7:491-502.
24. Horvath, C.M., Z. Wen, and J.E. Darnell. Jr. 1995. A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain. Genes Dev. 9:984-994.
25. Horvath, C.M., and J.E. Darnell, Jr. 1997. The state of the STATs: recent developments in the study of signal transduction to the nucleus. Curr. Opin. Cell Biol. 9:233-239.
26. Ihle, J.N. 1995. Cytokine receptor signaling. Nature (Lond.) 377:591-594.
27. Ihle, J.N. 1996. STATs and MAPKs: obligate or opportunistic partners in signaling. Bio Essays. 18:95-98.
28. Ihle, J.N., B.A. Witthuhn, F.W. Quelle, K. Yamamoto, W.E. Thierfelder, B. Kreider, and O. Silvennoinen. 1994. Signaling by the cytokine receptor superfamily: JAKs and STATs. Trends Biochem. Sci. 19:222-227.
29. Ip, N.Y., S.H. Nye, T.G. Boulton, S. Davis, T. Taga, Y. Li, S.J. Birren, K. Yasukawa, T. Kishimoto, D.J. Anderson, et al. 1992. CNTF and LIF act on neuronal cells via shared signaling pathways that involve the IL-6 signal transducing receptor component gp130. Cell. 69:1121-1132.
30. Kaptein, A., V. Paillard, and M. Saunders. 1996. Dominant negative stat3 mutant inhibits interleukin-6-induced Jak-STAT signal transduction. J. Biol. Chem. 271:5961-5964.
31. Kishimoto, T., T. Taga, and S. Akira. 1994. Cytokine signal transduction Cell. 76:253-262.
32. Kwon Kyu,T., M.A. Buchholz, F.J. Chrest, and A.A. Nordin. 1996. Staurosporine-induced G1 arrest is associated with the induction and accumulation of cyclin-dependent kinase inhibitors. Cell Growth Differ. 7:1305-1313.
33. Lamb, P., H.M. Seidel, J. Haslam, L. Milocco, L.V. Kessler, R.B. Stein, and J. Rosen. 1995. STAT protein complexes activated by interferon-gamma and gp130 signaling molecules differ in their sequence preferences and transcriptional induction properties. Nucleic Acids Res. 23:3283-3289.
34. Lutticken, C., U.M. Wegenka, J. Yuan, J. Buschmann, C. Schindler, A. Ziemiecki, A.G. Harpur, A.F. Wilks, K. Yasukawa, T. Taga, et al. 1994. Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130. Science (Wash. DC). 263:89-92.
35. Marshall, C.J. 1995. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation Cell. 80:179-185.
36. Megeney, L.A., R.L.S. Perry, J.E. Lecouter, and M.A. Rudnicki. 1996. bFGF and LIF signaling activates STAT3 in proliferating myoblasts. Dev. Genet. 19:139-145.
37. Minami, M., M. Inoue, S. Wei, K. Takeda, M. Matsumoto, T. Kishimoto, and S. Akira. 1996. STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line. Proc. Natl. Acad. Sci. USA. 93:3963-3966.
38. Nakajima, K., Y. Yamanaka, K. Nakae, H. Kojima, M. Ichiba, N. Kiuchi, T. Kitaoka, T. Fukada, M. Hibi, and T. Hirano. 1996. A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells. EMBO J. 15:3651-3658.
39. Nishida, E., and Y. Gotoh. 1993. The MAP kinase cascade is essential for diverse signal transduction pathways. Trends. Biochem. Sci. 18:128-131.
40. Pennica, D., W.I. Wood, and K.R. Chien. 1996. Cardiotrophin-1: a multifunctional cytokine that signals via LIF receptor-gp 130 dependent pathways. Cytokine Growth Factor Rev. 7:81-91.
41. Piquet-Pellorce, C., L. Grey, A. Mereau, and J.K. Heath. 1994. Are LIF and related cytokines functionally equivalent? Exp. Cell Res. 213:340-347.
42. Robertson, E.J. 1987. Embryo-derived stem cell lines. In Teratocarcinomas and Embryonic Stem Cells: A Practical Approach. E.J. Robertson, editor. IRL Press, Oxford. 71 pp.
43. Rose, T.M., D.M. Weiford, N.L. Gunderson, and A.C. Bruce. 1994. Oncostatin M (OSM) inhibits the differentiation of pluripotent embryonic stem cells in vitro. Cytokine. 6:48-54.
44. Sadowski, H.B., and M.Z. Gilman. 1993. Cell-free activation of a DNA-binding protein by epidermal growth factor. Nature (Lond.). 362:79-83.
45. Sadowski, H.B., K. Shuai, J.E. Darnell, Jr., and M.Z. Gilman. 1993. A common nuclear signal transduction pathway activated by growth factor and cylokine receptors. Science (Wash. DC). 261:1739-1744.
46. Sassone-Corsi, P., J.C. Sisson, and I.M. Verma. 1988. Transcriptional autoregulation of the proto-oncogene fos. Nature (Lond.). 334:314-319.
47. Satoh, T., Y. Uehara, and Y. Kaziro. 1992. Inhibition of interleukin 3 and gramilocyte-macrophage colony-stimulating factor stimulated increase of active Ras-GTP by Herbimycin A, a specific inhibitor of tyrosine kinases. J. Biol. Chem. 267:2537-2541.
48. Schaefer, T.S., L.K. Sanders, and D. Nathans. 1995. Cooperative transcriptional activity of Jun and Stat3b, a short form of STAT3. Proc. Natl. Acad. Sci. USA. 92:9097-9101.
49. Schiemann, W.P., L.M. Graves, H. Baumann, K.K. Morella, D.P. Gearing, M.D. Nielsen, E.G. Krebs, and N.M. Nathanson. 1995. Phosphorylation of the human leukemia inhibitory factor (LIF) receptor by mitogen-activated protein kinase and the regulation of LIF receptor function by heterologous receptor activation. Proc. Natl. Acad. Sci. USA. 92:5361-5365.
50. Schindler C., and J.E. Darnell, Jr. 1995. Transcriptional responses to polypeptide ligands: the JAK/STAT pathway. Annu. Rev. Biochem. 64: 621-651.
51. Shuai, K., C.M. Horvath, L.H. Huang, S.A. Qureshi, D. Cowburn, and J.E. Darnell, Jr. 1994. Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions. Cell. 76:821-828.
52. Stahl, N., T.G. Boulton, T. Farruggela, N.Y. Ip, S. Davis, B.A. Witthuhn, F.W. Quelle, O. Silvennoinen, G. Barbieri, S. Pellegrini, J. Ihle, and G.D. Yancopoulos. 1994. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL6b receptor components. Science (Wash. DC). 263: 92-95.
53. Stahl, N., T.J. Farruggella, T.G. Boulton, Z. Zhong, J.E. Darnell, Jr., and G.D. Yancopoulos. 1995. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science (Wash. DC). 267:1349-1353.
54. Stewart, C.L., P. Kaspar, L.J. Brunei, H. Bhatt, I. Gadi, F. Köntgen, and S.J. Abbondanzo. 1992. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature (Lond.). 359:76-79.
55. Takeda, K., K. Noguchi, W. Shi, T. Tanaka, M. Matsumoto, N. Yoshida, T. Kishimoto, and S. Akira. 1997. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc. Natl Acad. Sci. USA. 94: 3801-3804.
56. Taniguchi, T. 1995. Cytokine signaling through nonreceptor protein tyrosine kinases. Science (Wash. DC). 268:251-255.
57. Treisman, R. 1996. Regulation of transcription by MAP kinase cascades. Curr. Opin. Cell Biol. 8:205-215.
58. Wagner, B.J., T.E. Hayes, C.J. Hoban, and B.H. Cochran. 1990. The SIF binding element confers sis-PDGF inducibility onto the c-fos promoter. EMBO J. 9:4477-484.
59. Watanabe, S., and K. Arai. 1996. Roles of the JAK-STAT system in signal transduction via cytokine receptors. Curr. Opin. Genet. Dev. 6:587-596.
60. Wen, Z., Z. Zhong, and J.E. Darnell, Jr. 1995. Maximal activation by STAT1 and STAT3 requires both tyrosine and serine phosphorylation. Cell. 82:241-250.
61. Yin, T., and Y.C. Yang. 1994. Mitogen-activated protein kinases and ribosomal S6 protein kinases are involved in signaling pathways shared by interleukin-11, interleukin-6, leukemia inhibitory factor, and oncostatin M in mouse 3T3-L1 cells. J. Biol. Chem. 269:3731-3738.
62. Yu, C.L., D.J. Meyer, G.S. Campbell, A.C. Lamer, C. Carter-Su, J. Schwartz, and R. Jove. 1995. Enhanced DNA-binding activity of a STAT-3 related protein in cells transformed by the Src oncoprotein. Science (Wash. DC). 269:81-83.
63. Zajchowski, D.A., H. Boeuf, and C. Kedinger. 1985. The adenovirus-2 early EIIa transcription unit possesses two overlapping promoters with different sequence requirements for EIa-dependent stimulation. EMBO J. 5:1293-1300.
64. Zhang, X.K., J. Blenis, H.C. Li, C. Schindler, and S. Chenkiang. 1995. Requirement of serine phosporylation for formation of STAT-promoter complexes. Science (Wash. DC). 267:1990-1994.
65. Zhong, Z., Z. Wen, and J.E. Darnell, Jr. 1994. Stat3: a STAT family member activated by tyrosine phosporylation in response to epidermal growth factor and interleukin-6. Science (Wash. DC). 264:95-98.